ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Laboratory Industry Report
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Subscribe today for access to
Articles and Reports
Out with the Old: The 2024 Clinical Lab Experience
What challenges and opportunities affected the experience of medical lab professionals in 2024—and what might the new year bring?
FDA Watch: How Could the Change in US Government Affect IVDs and Labs?
Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
From - Laboratory Industry Report
The swirl of autumn leaves has brought a swirl of diagnostic deals. Here's a recap of the key activity from…
Medicare Reimbursement: Part B Lab Payments in Final Year before PAMA
From - Laboratory Industry Report
Part B payments for lab tests in 2017, the final year under the old reimbursement rules, totaled $7.1 billion, up slightly from…
Lab Leaders Have New Opportunities in the Age of Consumerism
From - Laboratory Industry Report
The G2 Power Panel provided attendees at the 36th annual Lab Institute (Oct. 24-26; Washington, D.C.) an opportunity to learn how some of…
Utilization Trends: Study Links EMR Prioritization to Over Ordering of Costly Lab Tests
...
Already a member? Log in here
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
...
Already a member? Log in here
Mindset Shift Moves Labs from Transactions to Insights
From - Laboratory Industry Report
How do you plan for the future in a rapidly changing environment? That is the big task that laboratories are being asked to do. There is no roadmap, yet their financial livelihood is dependent upon…
Latest Legal Challenge to ACA May Mean a Hot Mess for Insurance Markets
From - Laboratory Industry Report
After a series of setbacks, Republicans challenging the constitutionality of the Affordable Care Act (ACA) and its individual mandate are…
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
From - Laboratory Industry Report
Amid back to school season, companies were back to making diagnostic deals. Here's a recap of the key activity from…
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
From - Laboratory Industry Report
After a slow August, product launches were up in volume but not dramatic impact. Here's a rundown of the new diagnostics to hit the market in…
The End Comes for Theranos
...
Already a member? Log in here